Unknown

Dataset Information

0

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.


ABSTRACT: Emerging or re-emerging viruses are still major threats to public health. Prophylactic vaccines represent the most effective way to prevent virus infection; however, antivirals are more promising for those viruses against which vaccines are not effective enough or contemporarily unavailable. Because of the slow pace of novel antiviral discovery, the high disuse rates, and the substantial cost, repurposing of the well-characterized therapeutics, either approved or under investigation, is becoming an attractive strategy to identify the new directions to treat virus infections. In this review, we described recent progress in identifying broad-spectrum antivirals through drug repurposing. We defined the two major categories of the repurposed antivirals, direct-acting repurposed antivirals (DARA) and host-targeting repurposed antivirals (HTRA). Under each category, we summarized repurposed antivirals with potential broad-spectrum activity against a variety of viruses and discussed the possible mechanisms of action. Finally, we proposed the potential investigative directions of drug repurposing.

SUBMITTER: Li X 

PROVIDER: S-EPMC8129523 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9395782 | biostudies-literature
| S-EPMC10241557 | biostudies-literature
| S-EPMC5746591 | biostudies-literature
| S-EPMC8250478 | biostudies-literature
| S-EPMC9966946 | biostudies-literature
| S-EPMC4765712 | biostudies-other
| S-EPMC4876017 | biostudies-literature
| S-EPMC8180459 | biostudies-literature
| S-EPMC4637819 | biostudies-other
| S-EPMC7102765 | biostudies-literature